|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
139,126,000 |
Market
Cap: |
136.84(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0.8871 - $4.83 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile bluebird bio is a company focused on the pursuit of curative gene therapies for severe genetic diseases. Co. has late-stage clinical and research programs for the treatment of sickle cell disease (SCD), ss-thalassemia and cerebral adrenoleukodystrophy and is developing research to apply new technologies to these and other diseases. Using a proprietary lentiviral vector platform, Co. custom designs each of its therapies to address the underlying cause of disease by introducing a functional copy of a gene to patients' own isolated hematopoietic stem cells. Co. is developing lovotibeglogene autotemcel as a one-time treatment for patients with SCD.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
17,438 |
35,533 |
57,514 |
116,582 |
Total Sell Value |
$26,639 |
$61,294 |
$139,194 |
$443,003 |
Total People Sold |
3 |
5 |
5 |
9 |
Total Sell Transactions |
3 |
9 |
12 |
23 |
End Date |
2024-02-22 |
2023-11-21 |
2023-05-23 |
2022-05-23 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Davidson David |
Chief Medical Officer |
|
2015-12-15 |
4 |
OE |
$2.09 |
$2,090 |
D/D |
1,000 |
1,000 |
|
- |
|
Leschly Nick |
President and CEO |
|
2015-12-08 |
4 |
B |
$51.25 |
$501,007 |
I/I |
9,682 |
17,186 |
2.66 |
- |
|
Leschly Nick |
President and CEO |
|
2015-12-07 |
4 |
OE |
$2.09 |
$157,418 |
D/D |
66,720 |
313,241 |
|
- |
|
Sullivan Eric |
Principal Accounting Officer |
|
2015-12-02 |
4 |
AS |
$81.13 |
$33,751 |
D/D |
(416) |
3,218 |
|
- |
|
Sullivan Eric |
Principal Accounting Officer |
|
2015-12-02 |
4 |
OE |
$20.70 |
$9,237 |
D/D |
416 |
3,634 |
|
- |
|
Davidson David |
Chief Medical Officer |
|
2015-11-16 |
4 |
AS |
$70.60 |
$141,988 |
D/D |
(2,000) |
0 |
|
- |
|
Davidson David |
Chief Medical Officer |
|
2015-11-16 |
4 |
OE |
$2.09 |
$4,180 |
D/D |
2,000 |
2,000 |
|
- |
|
Walsh Jeffrey T. |
Chief Operating Officer |
|
2015-11-10 |
4 |
AS |
$74.60 |
$820,650 |
D/D |
(11,000) |
0 |
|
- |
|
Walsh Jeffrey T. |
Chief Operating Officer |
|
2015-11-10 |
4 |
OE |
$2.09 |
$22,990 |
D/D |
11,000 |
11,000 |
|
- |
|
Sullivan Eric |
Principal Accounting Officer |
|
2015-11-02 |
4 |
AS |
$77.87 |
$32,394 |
D/D |
(416) |
3,218 |
|
- |
|
Sullivan Eric |
Principal Accounting Officer |
|
2015-11-02 |
4 |
OE |
$20.70 |
$9,237 |
D/D |
416 |
3,634 |
|
- |
|
Davidson David |
Chief Medical Officer |
|
2015-10-15 |
4 |
AS |
$78.99 |
$159,399 |
D/D |
(2,000) |
0 |
|
- |
|
Davidson David |
Chief Medical Officer |
|
2015-10-15 |
4 |
OE |
$2.09 |
$4,180 |
D/D |
2,000 |
2,000 |
|
- |
|
Walsh Jeffrey T. |
Chief Operating Officer |
|
2015-10-12 |
4 |
AS |
$87.28 |
$968,634 |
D/D |
(11,000) |
0 |
|
- |
|
Walsh Jeffrey T. |
Chief Operating Officer |
|
2015-10-12 |
4 |
OE |
$2.09 |
$22,990 |
D/D |
11,000 |
11,000 |
|
- |
|
Cole Jason |
SVP, Secy. & General Counsel |
|
2015-10-09 |
4 |
AS |
$85.77 |
$434,541 |
D/D |
(5,000) |
0 |
|
- |
|
Cole Jason |
SVP, Secy. & General Counsel |
|
2015-10-09 |
4 |
OE |
$22.53 |
$112,650 |
D/D |
5,000 |
5,000 |
|
- |
|
Lynch Daniel |
Director |
|
2015-10-05 |
4 |
AS |
$100.23 |
$301,242 |
D/D |
(3,000) |
0 |
|
- |
|
Lynch Daniel |
Director |
|
2015-10-05 |
4 |
OE |
$2.09 |
$6,259 |
D/D |
3,000 |
3,000 |
|
- |
|
Sullivan Eric |
Principal Accounting Officer |
|
2015-10-02 |
4 |
AS |
$85.98 |
$35,820 |
D/D |
(416) |
3,218 |
|
- |
|
Sullivan Eric |
Principal Accounting Officer |
|
2015-10-02 |
4 |
OE |
$20.70 |
$9,237 |
D/D |
416 |
3,634 |
|
- |
|
Lynch Daniel |
Director |
|
2015-09-17 |
4 |
AS |
$140.06 |
$210,088 |
D/D |
(1,500) |
0 |
|
- |
|
Lynch Daniel |
Director |
|
2015-09-17 |
4 |
OE |
$2.09 |
$3,130 |
D/D |
1,500 |
1,500 |
|
- |
|
Davidson David |
Chief Medical Officer |
|
2015-09-15 |
4 |
AS |
$129.36 |
$259,962 |
D/D |
(2,000) |
0 |
|
- |
|
Davidson David |
Chief Medical Officer |
|
2015-09-15 |
4 |
OE |
$2.09 |
$4,180 |
D/D |
2,000 |
2,000 |
|
- |
|
939 Records found
|
|
Page 27 of 38 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|